Characteristics of patients potentially eligible for pharmacotherapy for ...

6 downloads 0 Views 580KB Size Report
Jul 7, 2005 - for weight loss in primary care practice in the United States ... properly cited, the use is non-commercial and no modifications or adaptations are ..... Tricare/Railroad/United Mine Workers ..... U.S. Food and Drug Administration.
Obesity Science & Practice

doi: 10.1002/osp4.46

ORIGINAL ARTICLE

Characteristics of patients potentially eligible for pharmacotherapy for weight loss in primary care practice in the United States Shumin Zhang1, Sudhakar Manne2, Jennifer Lin2 and Jiao Yang2 1

Epidemiology, Takeda Development Center Americas, Inc., Deerfield, IL USA; 2 Safety Statistics, Takeda Development Center Americas, Inc., Deerfield, IL USA Received 7 January 2016; revised 20 April 2016; accepted 21 April 2016 Address for correspondence: Shumin Zhang, MD, ScD, Takeda Development Center Americas, Inc., Deerfield, IL 60015, USA. E-mail: [email protected]

Summary Objective To describe the characteristics of real-world patients potentially eligible for adjunctive pharmacotherapy for weight loss.

Methods Patients from the GE Centricity electronic medical record database were selected if they 2 had body mass index (BMI) ≥30 or ≥27 to